“I think psilocybin gave me the impetus to stay abstinent. Psilocybin (pronounced silo-sie-bin) is what makes magic mushrooms psychedelic and, despite its reputation as a recreational drug for hippies, it is showing promise as a therapeutic agent for a number of psychiatric illnesses including addiction, depression and anxiety.
#Crack addiction recovery rate trial
McGlothlin was part of a small, proof-of-concept trial using psilocybin to help heavy smokers quit That was almost two years ago and McGlothlin says he is still smoke-free. The idea was that after he walked out of the research centre in the evening he would never smoke another cigarette again. So one December morning, McGlothlin walked into the research centre at Johns Hopkins University in Baltimore, Maryland, where he took a small, blue capsule and sat in a room listening to classical music. Then, McGlothlin’s friend told him about an advertisement for participants in a clinical trial of a new treatment for tobacco addiction. He tried to stop, using nicotine replacement therapy, psychological therapy or going cold turkey. Gordon McGlothlin is 65 years old and, until recently, he smoked 20 cigarettes a day, a habit he formed when he was just 15 years old. Matthew Johnson who conducted a proof-of-concept trial using psilocybin to help heavy smokers quit, sits back in one of the treatment rooms at Johns Hopkins University in Baltimore, Maryland Journal of Pharmaceutical Health Services Research.International Journal of Pharmacy Practice.Antimicrobial resistance and stewardship.